Radio and PodcastRadio and PodcastLive Radio & Podcasts
Raising $200M & Building AI for Drug Discovery BenchSci Co-founder and CEO, Liran Belenzon artwork
Business

Raising $200M & Building AI for Drug Discovery BenchSci Co-founder and CEO, Liran Belenzon

Innovation and Leadership with Jess Larsen by Graystoke Networks

May 28, 202643:58Business

Most people don’t realize how broken drug discovery really is. According to Liran Belenzon, companies can spend seven years and hundreds of millions of dollars on a drug candidate—only to see it fail in human trials. In...